Details
Description
In this report we described baseline characteristics and the duration of follow-up time among new users of 39 new molecular entities (NMEs) approved in 2014 and 45 NMEs approved in 2015 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD).